Intratumoral plasma cells: More than a predictive marker of response to anti-PD-L1 treatment in lung cancer?

ABSTRACT

In this issue of Cancer Cell, Patil et al. report that increased plasma cell signatures are predictive of an extended overall survival in non-small-cell lung cancer patients treated with a PD-L1 inhibitor and that these cells are associated with the presence of tertiary lymphoid structures.